Brain disorders: Impact of mild SARS-CoV-2 may shrink several parts of the brain

Puranam Revanth Kumar1, B Shilpa1, Rajesh Kumar Jha1

  • 1Department of Electronics and Communication Engineering, IcfaiTech (Faculty of Science and Technology), IFHE University, Hyderabad, India.

Insights

Even mild coronavirus (COVID-19) infection can cause significant brain changes, including shrinkage and tissue damage, impacting cognitive functions and mood for months. Further research into these persistent neurological effects is crucial.

Area of Science:

  • Neurology
  • Neuroscience
  • Infectious Diseases

Background:

  • Coronavirus disease (COVID-19), originating in Wuhan, China, has led to a global pandemic with severe health and societal consequences.
  • Beyond respiratory symptoms, COVID-19 has been linked to neurological complications, including encephalopathy.
  • The long-term neurological and cognitive sequelae of COVID-19 require thorough investigation.

Purpose of the Study:

  • To investigate the prolonged neurological clinical consequences and associated brain changes in individuals with mild COVID-19 infection.
  • To analyze the impact of COVID-19 on brain structure and function months after initial infection.

Main Methods:

  • Comparative analysis of brain imaging data between individuals who tested positive for COVID-19 and a control group.
  • Assessment of neurological and cognitive functions in patients post-mild COVID-19.

Main Results:

  • Individuals with a history of COVID-19 exhibited greater brain shrinkage, grey matter reduction, and tissue damage compared to controls.
  • Neurological damage was concentrated in brain regions associated with olfactory function, cognitive processing, and mood regulation.
  • These brain changes and associated symptoms, such as headaches and sensory abnormalities, persisted for several months post-infection.

Conclusions:

  • Mild COVID-19 infection can result in persistent, measurable changes in brain structure and function.
  • The findings underscore the necessity of monitoring for prolonged neurological signs in patients recovering from COVID-19.
  • Further research is warranted to understand the full spectrum of long-term neurological impacts of COVID-19.